Search by Drug Name or NDC

    NDC 73150-0200-12 UKONIQ 260.2 mg/1 Details

    UKONIQ 260.2 mg/1

    UKONIQ is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TG Therapeutics, Inc.. The primary component is UMBRALISIB TOSYLATE.

    Product Information

    NDC 73150-0200
    Product ID 73150-200_6f6fcaa4-e82f-4850-bf75-b5806f0478af
    Associated GPIs 21533080400320
    GCN Sequence Number 081907
    GCN Sequence Number Description umbralisib tosylate TABLET 200 MG ORAL
    HIC3 V1Q
    HIC3 Description ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS
    GCN 49168
    HICL Sequence Number 047104
    HICL Sequence Number Description UMBRALISIB TOSYLATE
    Brand/Generic Brand
    Proprietary Name UKONIQ
    Proprietary Name Suffix n/a
    Non-Proprietary Name umbralisib
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 260.2
    Active Ingredient Units mg/1
    Substance Name UMBRALISIB TOSYLATE
    Labeler Name TG Therapeutics, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA213176
    Listing Certified Through 2022-12-31

    Package

    NDC 73150-0200-12 (73150020012)

    NDC Package Code 73150-200-12
    Billing NDC 73150020012
    Package 4 CARTON in 1 CASE (73150-200-12) / 12 BOTTLE, PLASTIC in 1 CARTON / 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
    Marketing Start Date 2021-02-05
    NDC Exclude Flag N
    Pricing Information N/A